These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29032853)

  • 21. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration.
    Seddon JM; Francis PJ; George S; Schultz DW; Rosner B; Klein ML
    JAMA; 2007 Apr; 297(16):1793-800. PubMed ID: 17456821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype.
    Loane E; Nolan JM; McKay GJ; Beatty S
    Exp Eye Res; 2011 Nov; 93(5):592-8. PubMed ID: 21816153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re: Awh et al.: Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study (Ophthalmology 2015;122:162-9).
    Odaibo SG
    Ophthalmology; 2015 Oct; 122(10):e58. PubMed ID: 26398055
    [No Abstract]   [Full Text] [Related]  

  • 24. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
    Francis PJ; Hamon SC; Ott J; Weleber RG; Klein ML
    J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration.
    Seddon JM; Gensler G; Rosner B
    Ophthalmology; 2010 Aug; 117(8):1560-6. PubMed ID: 20346514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables.
    Seddon JM; Reynolds R; Maller J; Fagerness JA; Daly MJ; Rosner B
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2044-53. PubMed ID: 19117936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic susceptibility, dietary antioxidants, and long-term incidence of age-related macular degeneration in two populations.
    Wang JJ; Buitendijk GH; Rochtchina E; Lee KE; Klein BE; van Duijn CM; Flood VM; Meuer SM; Attia J; Myers C; Holliday EG; Tan AG; Smith WT; Iyengar SK; de Jong PT; Hofman A; Vingerling JR; Mitchell P; Klein R; Klaver CC
    Ophthalmology; 2014 Mar; 121(3):667-75. PubMed ID: 24290803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An association of neovascular age-related macular degeneration with polymorphisms of CFH, ARMS2, HTRA1 and C3 genes in Czech population.
    Matušková V; Zeman T; Ewerlingová L; Hlinomazová Z; Souček J; Vlková E; Goswami N; Balcar VJ; Šerý O
    Acta Ophthalmol; 2020 Sep; 98(6):e691-e699. PubMed ID: 31970928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
    Evans JR; Lawrenson JG
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD000254. PubMed ID: 28756618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of genetic base in the treatment of age-related macular degeneration.
    Gourgouli K; Gourgouli I; Tsaousis G; Spai S; Niskopoulou M; Efthimiopoulos S; Lamnissou K
    Int Ophthalmol; 2020 Apr; 40(4):985-997. PubMed ID: 31916060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lens status influences the association between CFH polymorphisms and age-related macular degeneration: findings from two population-based studies in Singapore.
    Wong CW; Liao J; Cheung GC; Khor CC; Vithana EN; Wang JJ; Mitchell P; Aung T; Wong TY; Cheng CY
    PLoS One; 2015; 10(3):e0119570. PubMed ID: 25786237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement factor H and LOC387715 gene polymorphisms in a Greek population with age-related macular degeneration.
    Marioli DI; Pharmakakis N; Deli A; Havvas I; Zarkadis IK
    Graefes Arch Clin Exp Ophthalmol; 2009 Nov; 247(11):1547-53. PubMed ID: 19568762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy.
    Perlee LT; Bansal AT; Gehrs K; Heier JS; Csaky K; Allikmets R; Oeth P; Paladino T; Farkas DH; Rawlings PL; Hageman GS
    Ophthalmology; 2013 Sep; 120(9):1880-92. PubMed ID: 23523162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common and rare genetic risk variants in age-related macular degeneration and genetic risk score in the Coimbra eye study.
    Farinha C; Barreto P; Coimbra R; Cachulo ML; Melo JB; Cunha-Vaz J; Lechanteur Y; Hoyng CB; Silva R
    Acta Ophthalmol; 2023 Mar; 101(2):185-199. PubMed ID: 36036675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of specific genetic polymorphisms with age-related macular degeneration in a northern Chinese population.
    Zhuang W; Li H; Liu Y; Zhao J; Ha S; Xiang W; Bai X; Li Z; Han Y; Sheng X
    Ophthalmic Genet; 2014 Sep; 35(3):156-61. PubMed ID: 24865190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic determinants of age-related macular degeneration in diverse populations from the PAGE study.
    Restrepo NA; Spencer KL; Goodloe R; Garrett TA; Heiss G; Bůžková P; Jorgensen N; Jensen RA; Matise TC; Hindorff LA; Klein BE; Klein R; Wong TY; Cheng CY; Cornes BK; Tai ES; Ritchie MD; Haines JL; Crawford DC
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6839-50. PubMed ID: 25205864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration.
    de Jong EK; Breukink MB; Schellevis RL; Bakker B; Mohr JK; Fauser S; Keunen JE; Hoyng CB; den Hollander AI; Boon CJ
    Ophthalmology; 2015 Mar; 122(3):562-70. PubMed ID: 25439433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CFH Y402H and ARMS2 A69S Polymorphisms and Oral Supplementation with Docosahexaenoic Acid in Neovascular Age-Related Macular Degeneration Patients: The NAT2 Study.
    Merle BM; Richard F; Benlian P; Puche N; Delcourt C; Souied EH
    PLoS One; 2015; 10(7):e0130816. PubMed ID: 26132079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alleles in the HtrA serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration.
    Deangelis MM; Ji F; Adams S; Morrison MA; Harring AJ; Sweeney MO; Capone A; Miller JW; Dryja TP; Ott J; Kim IK
    Ophthalmology; 2008 Jul; 115(7):1209-1215.e7. PubMed ID: 18164066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials.
    Lin LY; Zhou Q; Hagstrom S; Maguire MG; Daniel E; Grunwald JE; Martin DF; Ying GS;
    JAMA Ophthalmol; 2018 Jun; 136(6):682-688. PubMed ID: 29801032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.